Jolly good imaging firepower to illuminate the intricacies of the brain

The second oldest university in the English-speaking world is getting ready to install two of the newest diagnostic imaging machines on the market. Its hope is to change the game in the study of the brain.

The biomedical campus at Cambridge (Oxford is older) will add a 7T ultrahigh-field MRI scanner and a powerful PET-MRI companion in order advance researchers’ grasp of everything that touches cognition, from dementia to obesity and from pain to addiction.

The school’s website has the story, told in light of a Cambridge professor’s work to understand schizophrenia as it advances (or recedes) in the brains of adolescents: 

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Back in September, the FDA approved GE HealthCare’s new PET radiotracer, flurpiridaz F-18, for patients with known or suspected CAD. It is seen by many in the industry as a major step forward in patient care. 

After three years of intermittent shortages of nuclear imaging tracer technetium-99m pyrophosphate, there are no signs of the shortage abating.